Ali AlBahar/ LinkedIn
May 2, 2026, 05:23
Ali AlBahar: Ensuring Safety and Precision Across the Blood Transfusion Process
Ali AlBahar, Transfusion Medicine Specialist, Hematology and Blood Transfusion Researcher (MSc) at Ministry of Health Saudi Arabia, shared a post on LinkedIn:
“Blood transfusion is not a single act — it is a controlled clinical chain.
From donor selection to processing, testing, transfusion and monitoring, every step carries responsibility.
A small deviation at any point can impact patient safety.
This is not just a process… it is a system designed to prevent error before it happens.
In transfusion medicine: precision is not optional — it is essential.
BB.H.05 — The Transfusion Chain.
Blood Bank Educational Series.”
Stay updated with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering